Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1970
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 2
1972 2
1973 2
1974 3
1975 3
1976 3
1977 2
1978 4
1979 3
1980 2
1981 1
1982 4
1983 5
1984 2
1985 4
1986 3
1987 6
1988 5
1989 2
1990 9
1991 6
1992 7
1993 11
1994 7
1995 6
1996 12
1997 9
1998 8
1999 6
2000 13
2001 11
2002 12
2003 13
2004 7
2005 19
2006 8
2007 10
2008 9
2009 17
2010 17
2011 14
2012 12
2013 22
2014 15
2015 15
2016 7
2017 18
2018 15
2019 12
2020 16
2021 27
2022 15
2023 20
2024 17
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

480 results

Results by year

Filters applied: . Clear all
Page 1
Childhood Myelodysplastic Syndrome.
Chisholm KM, Bohling SD. Chisholm KM, et al. Clin Lab Med. 2023 Dec;43(4):639-655. doi: 10.1016/j.cll.2023.06.005. Epub 2023 Aug 7. Clin Lab Med. 2023. PMID: 37865508 Review.

Myelodysplastic syndrome (MDS) in children is rare, accounting for < 5% of all childhood hematologic malignancies. ...Herein, cMDS classification schema, clinical presentation, laboratory values, bone marrow histology, differential diagnostic consid

Myelodysplastic syndrome (MDS) in children is rare, accounting for < 5% of all childhood hematologic malignancies. ...Herei

Pediatric Myelodysplastic Syndromes.
Patel SS. Patel SS. Clin Lab Med. 2021 Sep;41(3):517-528. doi: 10.1016/j.cll.2021.03.015. Epub 2021 Jun 24. Clin Lab Med. 2021. PMID: 34304779 Review.
Pediatric myelodysplastic syndromes (MDS) comprise less than 5% of childhood malignancies. Approximately 30% to 45% of pediatric MDS cases are associated with an underlying genetic predisposition syndrome. ...
Pediatric myelodysplastic syndromes (MDS) comprise less than 5% of childhood malignancies. Approximately 30% to 45% of pediatric MDS …
Hepatitis-Associated Aplastic Anemia.
Alshaibani A, Dufour C, Risitano A, de Latour R, Aljurf M. Alshaibani A, et al. Hematol Oncol Stem Cell Ther. 2022 Jun 1;15(2):8-12. doi: 10.1016/j.hemonc.2020.10.001. Hematol Oncol Stem Cell Ther. 2022. PMID: 33197413 Free article. Review.
Hepatitis-associated aplastic anemia (HAAA) is a rare illness, characterized by onset of pancytopenia with a hypoplastic bone marrow that traditionally occurs within 6 months of an increase in serum aminotransferases. HAAA is observed in 1% to 5% of all newly …
Hepatitis-associated aplastic anemia (HAAA) is a rare illness, characterized by onset of pancytopenia with a hypoplastic bone marr
Beta-thalassemia.
Galanello R, Origa R. Galanello R, et al. Orphanet J Rare Dis. 2010 May 21;5:11. doi: 10.1186/1750-1172-5-11. Orphanet J Rare Dis. 2010. PMID: 20492708 Free PMC article. Review.
In some circumstances, spleen removal may be required. Bone marrow transplantation remains the only definitive cure currently available. Individuals with thalassemia intermedia may require splenectomy, folic acid supplementation, treatment of extramedullary erythrop …
In some circumstances, spleen removal may be required. Bone marrow transplantation remains the only definitive cure currently …
Approach to the diagnosis of aplastic anemia.
DeZern AE, Churpek JE. DeZern AE, et al. Blood Adv. 2021 Jun 22;5(12):2660-2671. doi: 10.1182/bloodadvances.2021004345. Blood Adv. 2021. PMID: 34156438 Free PMC article. Review.
Osteopetrosis.
Stark Z, Savarirayan R. Stark Z, et al. Orphanet J Rare Dis. 2009 Feb 20;4:5. doi: 10.1186/1750-1172-4-5. Orphanet J Rare Dis. 2009. PMID: 19232111 Free PMC article. Review.
Osteopetrosis ("marble bone disease") is a descriptive term that refers to a group of rare, heritable disorders of the skeleton characterized by increased bone density on radiographs. ...Treatment of osteopetrotic conditions is largely symptomatic, although h …
Osteopetrosis ("marble bone disease") is a descriptive term that refers to a group of rare, heritable disorders of the skeleto …
Anemia at older age: etiologies, clinical implications, and management.
Stauder R, Valent P, Theurl I. Stauder R, et al. Blood. 2018 Feb 1;131(5):505-514. doi: 10.1182/blood-2017-07-746446. Epub 2017 Nov 15. Blood. 2018. PMID: 29141943 Free article. Review.
Many underlying diseases, like myelodysplastic syndrome (MDS), develop preferentially in elderly individuals. The prevalence of anemia at older age is increasing, and this is mainly attributable to more frequently applied diagnostics and demographic changes in our societie …
Many underlying diseases, like myelodysplastic syndrome (MDS), develop preferentially in elderly individuals. The prevalence of anemi …
Macrophage function in adipose tissue homeostasis and metabolic inflammation.
Chavakis T, Alexaki VI, Ferrante AW Jr. Chavakis T, et al. Nat Immunol. 2023 May;24(5):757-766. doi: 10.1038/s41590-023-01479-0. Epub 2023 Apr 3. Nat Immunol. 2023. PMID: 37012544 Review.
Adverse consequences of AT metabolic inflammation might result from failure to maintain local lipid homeostasis and long-term effects on immune cells beyond the AT. ...Additionally, we hypothesize that trained immunity, which involves long-term functional adaptations of my …
Adverse consequences of AT metabolic inflammation might result from failure to maintain local lipid homeostasis and long-term effects …
[Acquired aplastic anemia].
Hosokawa K, Nakao S. Hosokawa K, et al. Rinsho Ketsueki. 2019;60(5):417-422. doi: 10.11406/rinketsu.60.417. Rinsho Ketsueki. 2019. PMID: 31168007 Review. Japanese.
The genomic landscape of AA is distinct from that of the myelodysplastic syndrome or age-related clonal hematopoiesis. This suggests that escape from an autoimmune attack is strongly associated with clonal hematopoiesis in AA. ...
The genomic landscape of AA is distinct from that of the myelodysplastic syndrome or age-related clonal hematopoiesis. This suggests …
Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.
Renaghan AD, Jaimes EA, Malyszko J, Perazella MA, Sprangers B, Rosner MH. Renaghan AD, et al. Clin J Am Soc Nephrol. 2020 Feb 7;15(2):289-297. doi: 10.2215/CJN.08580719. Epub 2019 Dec 13. Clin J Am Soc Nephrol. 2020. PMID: 31836598 Free PMC article. Review.
Hematopoietic stem cell transplantation is a life-saving therapy for many patients with cancer, as well as patients with some nonmalignant hematologic disorders, such as aplastic anemia, sickle cell disease, and certain congenital immune deficiencies. ...The cause is often …
Hematopoietic stem cell transplantation is a life-saving therapy for many patients with cancer, as well as patients with some nonmalignant h …
480 results